Corticosteroid therapy in COVID-19 patients: Don't forget venous thromboembolism.
作者信息
Roncon Loris, Zuin Marco, Zuliani Giovanni, Rigatelli Gianluca
机构信息
Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.
Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy; University of Ferrara, School of Medicine, Ferrara, Italy.
出版信息
Anaesth Crit Care Pain Med. 2021 Feb;40(1):100783. doi: 10.1016/j.accpm.2020.11.003. Epub 2020 Nov 19.
Abstract
摘要
相似文献
1
Corticosteroid therapy in COVID-19 patients: Don't forget venous thromboembolism.
Anaesth Crit Care Pain Med. 2021 Feb;40(1):100783. doi: 10.1016/j.accpm.2020.11.003. Epub 2020 Nov 19.
2
Ongoing trials on COVID-19 treatments: please, don't forget Venous Thromboembolism!
J Thromb Thrombolysis. 2021 May;51(4):1170-1171. doi: 10.1007/s11239-020-02366-3. Epub 2021 Jan 2.
3
Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621993573. doi: 10.1177/1076029621993573.
4
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
5
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
Thromb Res. 2021 Dec;208:170-172. doi: 10.1016/j.thromres.2021.11.008. Epub 2021 Nov 16.
6
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.
7
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024 Apr 6;403(10434):1337-1338. doi: 10.1016/S0140-6736(23)02882-9.
8
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024 Apr 6;403(10434):1339. doi: 10.1016/S0140-6736(23)02881-7.
9
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024 Apr 6;403(10434):1337. doi: 10.1016/S0140-6736(23)02880-5.
10
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024 Apr 6;403(10434):1338-1339. doi: 10.1016/S0140-6736(23)02884-2.
引用本文的文献
1
Acute pulmonary embolism with arrhythmia associated with minimal change disease in adults: a case report.
Front Cardiovasc Med. 2023 Aug 8;10:1182569. doi: 10.3389/fcvm.2023.1182569. eCollection 2023.
2
Corticosteroids for COVID-19: worth it or not?
Mol Biol Rep. 2022 Jan;49(1):567-576. doi: 10.1007/s11033-021-06793-0. Epub 2021 Oct 13.
本文引用的文献
1
COVID-19, steroids and other immunomodulators: The jigsaw is not complete.
Anaesth Crit Care Pain Med. 2020 Dec;39(6):699-701. doi: 10.1016/j.accpm.2020.10.011. Epub 2020 Oct 25.
2
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
JAMA Intern Med. 2013 May 13;173(9):743-52. doi: 10.1001/jamainternmed.2013.122.
4
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.
J Thromb Haemost. 2010 Nov;8(11):2483-93. doi: 10.1111/j.1538-7836.2010.04034.x.
5
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.
Thromb Res. 2006;118(2):247-52. doi: 10.1016/j.thromres.2005.06.006. Epub 2005 Jul 11.
Zotero 插件